Stock screenerAll disclosures →
EDGAR →
ACXP
Conviction 4HealthcareScan · Mon, Jul 20, 2026ACXP$1.54-0.97%
ResistanceSupportVol 14Vol MA14 100.24K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price1.54
Change-0.97%
Gap-1.29%
Rel volume0.19×
Avg volume94.18K
Avg $ vol146.11K
SMA 201.54
SMA 501.71
SMA 2003.15
Price vs 50-10.27%
Price vs 200-51.19%
MA stackbearish
50/200 cross—
Supertrenddown · 1.81
RSI (14)46
MACD hist0.02
MACD cross—
Stoch %K / %D36 / 40
ADX (14)18
+DI / −DI28 / 18
RSI divergenceBullish
MACD divergenceBullish
ATR %+8.88%
ADR %8.56%
52w high8.10
52w low0.2924
From 52w high-81.05%
Above 52w low+424.97%
New 52w highNo
SqueezeOn · 14d
Bollinger width23.91%
%B0.50
Donchian pos36.11%
Donchian high1.88
Donchian low1.34
AVWAP (52w high)4.82
vs AVWAP high-68.12%
AVWAP (52w low)4.78
vs AVWAP low-67.89%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d0.19×
Avg vol (14d)100.23K
Avg vol (20d)94.18K
Avg $ vol (20d)146.11K
Market cap6.6M
RS 3m (vs SPY)-43.68%
RS 6m (vs SPY)-51.10%
RS line new highNo
Trend template1/8
Technical rank16.1
1 week-2.85%
1 month-0.32%
3 months-35.50%
6 months-42.94%
1 year+241.87%
YTD-44.38%
P/E-0.83
P/B0.94
P/S—
P/FCF—
EPS-5.32
Div yield—
ROE-113.59%
ROA-83.51%
Debt/Eq—
Current2.44
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth43.51%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-7.86M
Revenue—
Net income-1.68M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.3M
Employees4
ListedFri, Jun 25, 2021
Free float2.53M
Float %88.6%
Short interest135.52K
Days to cover1.7d
Short volume55.6%
Squeeze score30 / 100
Next earningsFri, Aug 14, 2026 · pre-mkt (25d)
EPS forecast−$0.42 · 1 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank16.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.95
Support1.38
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ACXP
No recent disclosed trades by Congress in ACXP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ACXP · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LUCI DAVID P President and CEO · Stock Option · 2026-04-20 | Grant | 37.1K | $0 | 2026-04-20 | 2026-04-22 |
DELUCCIA ROBERT J Director · Stock Option · 2026-04-20 | Grant | 37.1K | $0 | 2026-04-20 | 2026-04-22 |
Scodari Joseph C Director · Stock Option · 2026-04-20 | Grant | 2.15K | $0 | 2026-04-20 | 2026-04-22 |
Shawah Robert G. Chief Financial Officer · Stock Option · 2026-04-20 | Grant | 25.9K | $0 | 2026-04-20 | 2026-04-22 |
HARRISON THOMAS L Director · Stock Option · 2026-04-20 | Grant | 2.15K | $0 | 2026-04-20 | 2026-04-22 |
Sailer Carl Director · Stock Option · 2026-04-20 | Grant | 2.15K | $0 | 2026-04-20 | 2026-04-22 |
DEAN JACK H Director · Stock Option · 2026-04-20 | Grant | 2.15K | $0 | 2026-04-20 | 2026-04-22 |
Donohue James J. Director · Stock Option · 2026-04-20 | Grant | 2.15K | $0 | 2026-04-20 | 2026-04-22 |
SEC filings
EDGAR filings in ACXP
No recent SEC filings on file for ACXP.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.